AstraZeneca and Oxford University are also expected to start similarly sized trials in August, followed by Johnson & Johnson in September. AstraZeneca and Oxford University are also expected to start similarly sized trials in August, followed by Johnson & Johnson in September. In Africa, South Africa became the first country to start clinical trials of the ChAdOx1 vaccine, a weakened and non-replicating form of a common cold virus (adenovirus). While progress has been made in Covid-19 vaccine and drug development, some of the drugs on clinical trials have failed. The drug, which was being tested in conjunction with Regeneron Pharmaceuticals, was reported to have failed in Phase III clinical trial.

Source: Daily Nation July 06, 2020 04:52 UTC